Biosynth to Acquire Trinity Biotech's Life Sciences Supply Business for $30M
Trinity said it is selling the business to focus on its core operations in diabetes care, decentralized patient monitoring, and diagnostic solutions.
Source: 360dx.com
Page 37 - Trinity Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Trinity Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Trinity Biotech Today - Breaking & Trending Today
Trinity Biotech sells life sciences supply business in $30m deal
Nasdaq-listed company said life sciences supply is no longer core to its long-term strategy
Source: businesspost.ie
ADRs End Mostly Lower; Braskem, Trinity Biotech Trade Actively - Stock market news
By Denny Jacob International stocks trading in New York closed mostly lower on Thursday. The S&P/BNY Mellon index of American depositary receipts ticked down 0.3% to 152.86. The European index ticked down 0.2% to 151.54. The Asian index re... | Apr. 20
Source: marketscreener.com
Trinity Biotech (NASDAQ:TRIB) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Rating) in a research note issued to investors on Friday morning. The brokerage issued a buy rating on the stock. Trinity Biotech Stock Up 2.4 % Shares of Trinity Biotech stock opened at $0.86 on Friday. The company has a debt-to-equity ratio of 8.70, […]
Source: wkrb13.com
Next Generation Technology the Future of HIV Rapid Test Kits Market; the Market is Set to Reach 1.68 Billion by 2028 - Arizton |
The research study on HIV rapid test kits market - global outlook & forecast 2023-2028, recently published by Arizton Advisory & Intelligence
Source: medgadget.com